Summit Trail Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Summit Trail Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $356,840 - $756,521	-2,780 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $14,782 - $19,214	-70 Reduced 2.46%	2,780 $763,000
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $1.8 Million - $2.48 Million	-11,926 Reduced 80.71%	2,850 $590,000
Q1 2018 May 22, 2018	SELL	$138.63 - $182.62 $268 Million - $353 Million	-1,933,954 Reduced 99.24%	14,776 $1.95 Million
Q1 2018 May 21, 2018	BUY	$138.63 - $182.62 $268 Million - $353 Million	1,935,379 Added 14496.14%	1,948,730 $1.95 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $1.71 Million - $1.96 Million	13,351	13,351 $2.14 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.